423 related articles for article (PubMed ID: 10764145)
1. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.
O'Gorman DM; McKenna SL; McGahon AJ; Knox KA; Cotter TG
Leukemia; 2000 Apr; 14(4):602-11. PubMed ID: 10764145
[TBL] [Abstract][Full Text] [Related]
2. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
3. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.
Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S
J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242
[TBL] [Abstract][Full Text] [Related]
4. Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury.
Hu Z; Sayeed MM
Am J Physiol Cell Physiol; 2005 May; 288(5):C1171-8. PubMed ID: 15625305
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias.
Zhao S; Konopleva M; Cabreira-Hansen M; Xie Z; Hu W; Milella M; Estrov Z; Mills GB; Andreeff M
Leukemia; 2004 Feb; 18(2):267-75. PubMed ID: 14628071
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
8. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
9. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
11. Apigenin and LY294002 prolong EGF-stimulated ERK1/2 activation in PC12 cells but are unable to induce full differentiation.
Llorens F; Garcia L; Itarte E; Gómez N
FEBS Lett; 2002 Jan; 510(3):149-53. PubMed ID: 11801244
[TBL] [Abstract][Full Text] [Related]
12. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
[TBL] [Abstract][Full Text] [Related]
13. PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways.
Grandage VL; Gale RE; Linch DC; Khwaja A
Leukemia; 2005 Apr; 19(4):586-94. PubMed ID: 15703783
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity to apoptosis between the human small and large intestinal mucosae: linkage with segment-specific regulation of BCL-2 homologs and involvement of signaling pathways.
Gauthier R; Laprise P; Cardin E; Harnois C; Plourde A; Reed JC; Vézina A; Vachon PH
J Cell Biochem; 2001; 82(2):339-55. PubMed ID: 11527158
[TBL] [Abstract][Full Text] [Related]
15. Downstream effectors of oncogenic ras in multiple myeloma cells.
Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells.
Hemström TH; Sandström M; Zhivotovsky B
Int J Cancer; 2006 Sep; 119(5):1028-38. PubMed ID: 16570272
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.
del Peso L; González-García M; Page C; Herrera R; Nuñez G
Science; 1997 Oct; 278(5338):687-9. PubMed ID: 9381178
[TBL] [Abstract][Full Text] [Related]
18. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways.
Huang HM; Huang CJ; Yen JJ
Blood; 2000 Sep; 96(5):1764-71. PubMed ID: 10961875
[TBL] [Abstract][Full Text] [Related]
19. Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis.
Marushige K; Marushige Y
Anticancer Res; 1999; 19(5B):3865-71. PubMed ID: 10628325
[TBL] [Abstract][Full Text] [Related]
20. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.
Bai RY; Ouyang T; Miething C; Morris SW; Peschel C; Duyster J
Blood; 2000 Dec; 96(13):4319-27. PubMed ID: 11110708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
